VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > No sales yet for 2022

<< Previous

Bullboard Posts

Next >>

Post by WalkOverTheStrton Jun 21, 2022 8:31am

176 Views

Post# 34770689

No sales yet for 2022

Those that pump every day ignore the fact that Ventripoint has yet to make any sales (even placement conversions). You can like the tech, the 15 studies, GE HC relationship (has not launched just on the vivid website...) but you can call a spade a spade. NO SALES YET......
I don't post here often as this board is monopolized by a constant pumper who never can be objective.
I'd also bet that many here reading the posts of that pumper own more shares than he/she....

<< Previous

Bullboard Posts

Next >>

Xplore Resources to expand position near Surge Lithium Project